{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:09:12Z","timestamp":1792624152465,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ijid.2020.06.007","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T21:02:12Z","timestamp":1591650132000},"page":"270-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["In vitro efficacy of combinations of eight antimicrobial agents against Mycobacteroides abscessus complex"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5225-7911","authenticated-orcid":false,"given":"Masahiro","family":"Shirata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuta","family":"Yoshimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Marumo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoko","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motonari","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijid.2020.06.007_bib0005","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1128\/JCM.02950-14","article-title":"Utility of sequencing the erm(41) gene in isolates of Mycobacterium abscessus subsp. abscessus with low and intermediate clarithromycin MICs","volume":"53","author":"Brown-Elliott","year":"2015","journal-title":"J Clin Microbiol"},{"issue":"2","key":"10.1016\/j.ijid.2020.06.007_bib0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.diagmicrobio.2018.08.008","article-title":"Drug susceptibility patterns of Mycobacterium abscessus and Mycobacterium massiliense isolated from respiratory specimens","volume":"93","author":"Cho","year":"2019","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"7","key":"10.1016\/j.ijid.2020.06.007_bib0015","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1128\/AAC.00685-12","article-title":"Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense","volume":"56","author":"Choi","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"10.1016\/j.ijid.2020.06.007_bib0020","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1128\/JCM.01121-14","article-title":"When does 2 plus 2 equal 5? A review of antimicrobial synergy testing","volume":"52","author":"Doern","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.ijid.2020.06.007_bib0025","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.ijid.2020.06.007_bib0030","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1128\/JCM.01175-12","article-title":"Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases","volume":"50","author":"Harada","year":"2012","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.ijid.2020.06.007_bib0035","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0732-8893(93)90087-N","article-title":"Synergy assessed by checkerboard. A critical analysis","volume":"16","author":"Hsieh","year":"1993","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2020.06.007_bib0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1128\/AAC.49.1.45-51.2005","article-title":"In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus","volume":"49","author":"Jacqueline","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.ijid.2020.06.007_bib0045","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1128\/AAC.01158-15","article-title":"Carbapenems and rifampin exhibit synergy against Mycobacterium tuberculosis and Mycobacterium abscessus","volume":"59","author":"Kaushik","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.ijid.2020.06.007_bib0050","doi-asserted-by":"crossref","first-page":"e00470","DOI":"10.1128\/AAC.00470-19","article-title":"In vitro activity of new tetracycline analogs omadacycline and eravacycline against drug-resistant clinical isolates of Mycobacterium abscessus","volume":"63","author":"Kaushik","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.ijid.2020.06.007_bib0055","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1348-0421.2010.00221.x","article-title":"Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns","volume":"54","author":"Kim","year":"2010","journal-title":"Microbiol Immunol"},{"issue":"3","key":"10.1016\/j.ijid.2020.06.007_bib0060","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1164\/rccm.201003-0395OC","article-title":"Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus","volume":"183","author":"Koh","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ijid.2020.06.007_bib0065","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01991-2018","article-title":"Mycobacterium abscessus pulmonary disease: individual patient data meta-analysis","volume":"54","author":"Kwak","year":"2019","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.ijid.2020.06.007_bib0070","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1093\/jac\/dkx212","article-title":"Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan","volume":"72","author":"Lee","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.ijid.2020.06.007_bib0075","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/jac\/dkw022","article-title":"Bactericidal and intracellular activity of \u03b2-lactams against Mycobacterium abscessus","volume":"71","author":"Lefebvre","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.ijid.2020.06.007_bib0080","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijantimicag.2007.05.003","article-title":"In vitro efficacy of imipenem in combination with six antimicrobial agents against Mycobacterium abscessus","volume":"30","author":"Miyasaka","year":"2007","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.ijid.2020.06.007_bib0085","first-page":"e00943","article-title":"Selection of resistance to clarithromycin in Mycobacterium abscessus subspecies","volume":"61","author":"Mougari","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ijid.2020.06.007_bib0090","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1128\/JCM.01327-13","article-title":"Discrimination of Mycobacterium abscessus subsp. massiliense from Mycobacterium abscessus subsp. abscessus in clinical isolates by multiplex PCR","volume":"52","author":"Nakanaga","year":"2014","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2020.06.007_bib0095","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12879-016-1689-6","article-title":"Clinical efficacy and safety of multidrug therapy including thrice weekly intravenous amikacin administration for Mycobacterium abscessus pulmonary disease in outpatient settings: a case series","volume":"16","author":"Namkoong","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"4","key":"10.1016\/j.ijid.2020.06.007_bib0100","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.01275-08","article-title":"A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae","volume":"53","author":"Nash","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.ijid.2020.06.007_bib0105","first-page":"29","article-title":"Effect of antibiotic combinations by \u201cBreak-point Checkerboard Plate\u201d against multidrug-resistant Pseudomonas aeruginosa","volume":"59","author":"Nishio","year":"2011","journal-title":"Japanese journal of chemotherapy"},{"issue":"1","key":"10.1016\/j.ijid.2020.06.007_bib0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.ijid.2020.06.007_bib0115","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/cid\/ciw723","article-title":"Progression and treatment outcomes of lung disease caused by Mycobacterium abscessus and Mycobacterium massiliense","volume":"64","author":"Park","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.ijid.2020.06.007_bib0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0033-1333575","article-title":"Management of nontuberculous mycobacterial (NTM) lung disease","volume":"34","author":"Philley","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.ijid.2020.06.007_bib0125","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1128\/JCM.01257-09","article-title":"Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in France","volume":"47","author":"Roux","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.ijid.2020.06.007_bib0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.prrv.2007.04.006","article-title":"Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: \u2018the motion for\u2019","volume":"8","author":"Saiman","year":"2007","journal-title":"Paediatr Respir Rev"},{"key":"10.1016\/j.ijid.2020.06.007_bib0135","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/1471-2164-15-359","article-title":"Genome analysis reveals three genomospecies in Mycobacterium abscessus","volume":"15","author":"Sassi","year":"2014","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ijid.2020.06.007_bib0140","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.3389\/fmicb.2018.02273","article-title":"Mycobacterium abscessus and \u03b2-lactams: emerging insights and potential opportunities","volume":"9","author":"Story-Roller","year":"2018","journal-title":"Front Microbiol"},{"issue":"8","key":"10.1016\/j.ijid.2020.06.007_bib0145","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00614-19","article-title":"Synergistic efficacy of \u03b2-lactam combinations against Mycobacterium abscessus pulmonary infection in mice","volume":"63","author":"Story-Roller","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.ijid.2020.06.007_bib0150","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s10156-002-0176-8","article-title":"Successful treatment with faropenem and clarithromycin of pulmonary Mycobacterium abscessus infection","volume":"8","author":"Tanaka","year":"2002","journal-title":"J Infect Chemother"},{"issue":"4","key":"10.1016\/j.ijid.2020.06.007_bib0155","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1080\/00365540500440353","article-title":"Break-point Checkerboard Plate\u2019 for screening of appropriate antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa","volume":"38","author":"Tateda","year":"2006","journal-title":"Scand J Infect Dis"},{"issue":"10","key":"10.1016\/j.ijid.2020.06.007_bib0160","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1469-0691.2009.03013.x","article-title":"Environmental sources of rapid growing nontuberculous mycobacteria causing disease in humans","volume":"15","author":"van Ingen","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2020.06.007_bib0165","first-page":"47","article-title":"Application of DNA-DNA hybridization DDH mycobacteria \u2018Kyokuto\u2019 to species-identification of mycobacteria grown in Middlebrook 7H9 broth","volume":"11","author":"Wada","year":"2000","journal-title":"JARMAM"},{"key":"10.1016\/j.ijid.2020.06.007_bib0170","series-title":"Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes","author":"Woods","year":"2011"},{"issue":"2","key":"10.1016\/j.ijid.2020.06.007_bib0175","doi-asserted-by":"crossref","first-page":"e01842","DOI":"10.1128\/AAC.01842-18","article-title":"Molecular analysis of linezolid-resistant clinical isolates of Mycobacterium abscessus","volume":"63","author":"Ye","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.ijid.2020.06.007_bib0180","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1128\/JCM.01688-08","article-title":"Cohort study of molecular identification and typing of Mycobacterium abscessus, Mycobacterium massiliense, and Mycobacterium bolletii","volume":"47","author":"Zelazny","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.ijid.2020.06.007_bib0185","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ijantimicag.2016.12.003","article-title":"In vitro activity of clarithromycin in combination with other antimicrobial agents against Mycobacterium abscessus and Mycobacterium massiliense","volume":"49","author":"Zhang","year":"2017","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1016\/j.ijid.2020.06.007_bib0190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.diagmicrobio.2017.09.013","article-title":"In vitro activity between linezolid and other antimicrobial agents against Mycobacterium abscessus complex","volume":"90","author":"Zhang","year":"2018","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220304422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220304422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:52:59Z","timestamp":1761119579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220304422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":38,"alternative-id":["S1201971220304422"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.06.007","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro efficacy of combinations of eight antimicrobial agents against Mycobacteroides abscessus complex","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}